UBS Group
MRND

UBS Group’s IQ U.S. Mid Cap R&D Leaders ETF MRND Stock Holding History

UBS Group’s Portfolio MRND Stock Details MRND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-486
Closed -$9.53K – 10950
2022
Q4 		$9.53K Sell
486
-12
-2% -$241 ﹤0.01% 8638
2022
Q3 		$9K Hold
498
– – ﹤0.01% 8633
2022
Q2 		$10K Buy
+498
New +$11K ﹤0.01% 8048

Other funds holding MRND

NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

UBS Group's MRND Position: Q1 2023 in Review

UBS Group sold out of IQ U.S. Mid Cap R&D Leaders ETF (MRND) in Q1 2023, closing a stake of 486 shares — an estimated $9.53K sold.

UBS Group first reported a position in MRND in Q2 2022 and held it in 3 quarters. The position peaked at $10K in Q2 2022. 1 fund tracked by Wall St. Rank holds MRND as of Q1 2023.

  • UBS Group reported no remaining IQ U.S. Mid Cap R&D Leaders ETF position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 486 IQ U.S. Mid Cap R&D Leaders ETF shares in Q1 2023, an estimated $9.53K.
  • UBS Group first reported a position in IQ U.S. Mid Cap R&D Leaders ETF in Q2 2022 and held it in 3 quarters.
  • UBS Group's IQ U.S. Mid Cap R&D Leaders ETF position peaked at $10K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held IQ U.S. Mid Cap R&D Leaders ETF as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.